MDXG (mimedx.com) Bozor qiymatining balans qiymatiga nisbati

MiMedx Group Inc (MDXG) kompaniyasining rasmiy ramzlari

MiMedx Group, Inc. (MDXG) bio-implantlarga bo'lgan barqaror talabni ta'minlovchi eksklyuziv PURION texnologiyasi tufayli regenerativ terapiya segmentida ustunlikka ega. Kompaniya qimmatli qog'ozlarining bozor dinamikasi, bunda ko'rsatkich 2.59 darajasida turibdi, jarrohlik amaliyotlari hajmi va Medicare to'lovlariga bo'lgan bog'liqlikni hisobga oladi. Biroq, huquqiy nizolar va inson to'qimalari mahsulotlarining tasnifi bo'yicha tartibga soluvchi noaniqliklar o'sishga to'sqinlik qilishda davom etmoqda.

MDXG MiMedx Corp: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.10.2026 oraligʻida
MiMedx Group original mahsuloti

Ushbu ko'rsatkich sof aktivlardan yuqori bo'lgan bozor qiymati premiumini o'lchaydi va investorlarning aksiyalar uchun uning balans qiymatiga nisbatan qanchalik premium to'lashga tayyorligini ko'rsatadi. Bozor qiymatining balans qiymatiga nisbatini tahlil qilish MiMedx Group, Inc. (MDXG) kompaniyasining kengayish potentsialini baholash imkonini beradi, bunda regenerativ texnologiyalarni takrorlashning yuqori marjalari ko'pincha aksiyalar narxining balans qiymatidan sezilarli darajada farqlanishini asoslaydi.

Asosiy raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati ASND (Ascendis Pharma A/S)|MDGL (madrigalpharma.com) - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati Corcept Therapeutics Incorporated CORT|Sof aktivlarga nisbatan bozor kapitallashuvi Rhythm Pharma|Akero Therapeutics Inc (AKRO) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Metsera Therapeutics (MTSR)|Bozor kapitallashuvining balans qiymatiga nisbati MLTX (MoonLake Immunotherapeutics)|crinetics.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NewAmsterdam Pharma Company N.V. (NAMS)|SLNO: Balans qiymatiga nisbatan bozor qiymati|FOLD (Amicus Pharma) - Bozor qiymatining balans qiymatiga nisbati|89bio Pharma (ETNB) - Kapitallashuvning sof aktivlarga nisbati|AGIO (Agios Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati structuretx.com (GPCR)|Rezolute (RZLT) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati LXRX (Lexicon Pharmaceuticals Inc)|MBX Bio - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Altimmune Pharma ALT|AARD (Aardvark Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|sagimet.com (SGMT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|BIOA - Kapitallashuvning sof aktivlarga nisbati|Biomea Fusion Inc (BMEA) - Bozor kapitallashuvining balans qiymatiga multiplikatori|QNCX (Quince Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Fractyl Health, Inc|Bozor kapitallashuvining balans qiymatiga nisbati vTv Therapeutics Inc. (VTVT)|Bozor qiymatining balans qiymatiga nisbati ATPC (agapeatpgroup.com)|PLUR: Bozor qiymatining balans qiymatiga nisbati|Synlogic Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|LPCN - Bozor qiymatining balans qiymatiga nisbati|MTNB - Bozor qiymatining balans qiymatiga nisbati|Spruce Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|GLTO (galecto.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|CTCX: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi LUMO|Bozor qiymatining balans qiymatiga nisbati ONVO (Organovo Holdings Inc)|Kapitallashuvning sof aktivlarga nisbati RDUS (Radius Pharmaceuticals)